A retrospective study of early post liver transplant rescue treatment with sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) for 12 weeks
Latest Information Update: 23 Aug 2022
At a glance
- Drugs Sofosbuvir/velpatasvir/voxilaprevir (Primary)
- Indications Transplant rejection
- Focus Therapeutic Use
Most Recent Events
- 23 Aug 2022 New trial record
- 26 Jun 2022 Results (n=6) presented at The International Liver Congress 2022.